🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to document the safety of tecemotide (L-BLP25) pha...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00157196
Treatments Being Tested
The purpose of this study is to understand whether the couple therapy that ...
Status
Terminated
Location
University Hospitals Cleveland Medical Center
Start Date
2016-01-19
Trial ID
NCT03498638
Treatments Being Tested
In 2019 VA mandated that all Veterans seeking mental health care have acces...
Status
Completed
Location
VA San Diego Healthcare System, San Diego, CA
Start Date
2022-01-17
Trial ID
NCT05207436
Treatments Being Tested
Tecemotide (L-BLP25) is believed to induce a Mucinous glycoprotein 1 (MUC1)...
Status
Completed
Location
Please Contact the Merck KGaA Communication Center
Start Date
2008-01
Trial ID
NCT01094548
The goal of this study is to construct and assess a theoretical and interve...
Status
Completed
Location
"Shalhevet" and "Savion" day centers; "Milav" social clubs
Start Date
2023-07-06
Trial ID
NCT05948735
Non-specific neck pain is a common problem that doesn't have a specific cau...
Status
Recruiting
Location
Ibne sina hospital and research institute.
Start Date
2026-06-20
Trial ID
NCT07725861
Treatments Being Tested
The original purpose of the study is to assess the long-term safety, tolera...
Status
Completed
Location
Multiple Locations
Start Date
2010-07-28
Trial ID
NCT01175213
The primary goal of this study is to develop and test a depression-specific...
Status
Completed
Location
Duke Child & Family Studies Center; Duke University Medical Center
Start Date
2006-07
Trial ID
NCT00612807
The drug being tested is called VigantOL® oil - a very effective form of Vi...
Status
Completed
Location
Research Site
Start Date
2011-02
Trial ID
NCT01285401
This is a Phase II, single institution open-label, non-randomized monothera...
Status
Active Not Recruiting
Location
Ohio State University Medical Center
Start Date
2012-05-21
Trial ID
NCT01589302
Treatments Being Tested